文献速递消化系统肿瘤

国家癌症登记中胰腺癌被低估——重新审视发病率和生存率

Underestimation of pancreatic cancer in the national cancer registry - Reconsidering the incidence and survival rates.
PubMed 文献 · Eur J Cancer · 2016-12-26

该研究基于鹿特丹研究(RS)前瞻性人群队列(1989至2006年入组,随访至2013年),在14,922名基线风险人群中识别出113例胰腺癌,年龄标化发病率在75岁以上人群为每10万人年109.9(95%CI 85.7-138.8),高于荷兰癌症登记报告值;RS识别的113例中仅67.3%被国家癌症登记收录,未登记病例年龄显著更大且生存显著更差,作者认为国家登记低估胰腺癌发病率并可能高估其生存率。

要点

  • 荷兰癌症登记中胰腺癌发病率被低估,RS队列75岁以上人群发病率为109.9/10万人年。
  • RS识别的113例胰腺癌中仅67.3%被国家癌症登记收录。
  • 未被登记的胰腺癌病例年龄显著更大且生存显著更差。

核心结论

  • 荷兰癌症登记报告的胰腺癌发病率存在低估;未被登记的病例生存显著更差,因此可能高估了胰腺癌本已很差的生存率。

研究设计与样本

  • 研究嵌入鹿特丹研究(RS),为正在进行的基于人群的前瞻性队列研究,纳入1989至2006年间45岁及以上人群,胰腺癌发病信息可获取至2013年。
  • 基线14,922名参与者存在胰腺癌发病风险,中位随访时间为每人16.4人年。
  • 计算年龄别发病率并与荷兰癌症登记数据比较。

主要发现

  • 共113名参与者发生胰腺癌。
  • 75岁以上人群发病率为每10万人年109.9(95%CI 85.7-138.8),高于当前报告的每10万人年55.9-89.2。
  • RS识别的113例中仅67.3%被荷兰癌症登记报告为胰腺癌。
  • 未被登记的病例年龄显著更大且生存显著更差。

关键数值与推荐

  • 75岁以上人群胰腺癌发病率为每10万人年109.9(95%CI 85.7-138.8),对比当前报告值每10万人年55.9-89.2。
  • RS识别的胰腺癌病例中被荷兰癌症登记收录的比例为67.3%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the Netherlands, like in many other European countries, pancreatic cancer mortality was found to be systematically higher than the incidence. This suggests that there is an underestimation of the reported incidence of pancreatic cancer. AIM: We aimed to study the incidence of pancreatic cancer in the Rotterdam area and to compare this with the national level. METHODS: This study is embedded in the Rotterdam Study (RS), an ongoing population-based prospective cohort study of people aged 45 years and above, enrolled between 1989 till 2006. Details on incident pancreatic cancer cases were available until 2013. Age-specific incidence rates were calculated and compared with data available in the Netherlands Cancer Registry. RESULTS: At baseline 14,922 participants were at risk of developing pancreatic cancer. Median follow-up time was 16.4 person years per person. In total, 113 participants developed pancreatic cancer. Rates increased with age with an incidence rate of 109.9 (95% confidence interval [CI]; 85.7-138.8) per 100,000 person years for people older than 75. This is higher than the currently reported 55.9-89.2 per 100,000 person year. Of the 113 cases identified in the RS, only 67.3% was reported as pancreatic cancer in the Netherlands Cancer Registry. Cases that were not registered were significantly older and had significantly poorer survival. CONCLUSION: The incidence of pancreatic cancer, as registered by the Netherlands Cancer Registry, is an underestimation. Patients, not registered by the cancer registry, have a significantly poorer survival. Consequently, we probably overestimate the already poor survival of pancreatic cancer.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Fest J, Ruiter R, van Rooij FJ, et al. Underestimation of pancreatic cancer in the national cancer registry - Reconsidering the incidence and survival rates. Eur J Cancer. 2016. PMID: 28033529. doi:10.1016/j.ejca.2016.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。